Bruker Overview
- Year Founded
-
1960

- Status
-
Public
- Employees
-
8,525

- Stock Symbol
-
BRKR

- Investments
-
84
- Share Price
-
$67.97
- (As of Friday Closing)
Bruker General Information
Description
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives a majority of its revenue from Europe.
Contact Information
- 40 Manning Road
- Billerica, MA 01821
- United States
Bruker Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$67.97 | $68.80 | $53.79 - $84.84 | $9.5B | 138M | 840K | $2.17 |
Bruker Financials Summary
In Thousands, USD |
TTM 30-Sep-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
---|---|---|---|---|
EV | 9,848,948 | 10,597,404 | 12,896,890 | 8,553,242 |
Revenue | 2,818,400 | 2,530,700 | 2,417,900 | 1,987,500 |
EBITDA | 535,000 | 514,700 | 496,100 | 317,400 |
Net Income | 319,100 | 296,600 | 277,100 | 157,800 |
Total Assets | 3,819,600 | 3,611,800 | 3,650,000 | 3,049,000 |
Total Debt | 1,219,600 | 1,270,400 | 1,393,900 | 912,800 |
Bruker Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Bruker Comparisons
Industry
Financing
Details
Bruker Competitors (8)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Revvity | Corporation | Waltham, MA | 00000 | 00.000 | 000000000 | 00.000 |
00000-00000000 000 | Formerly PE-Backed | Raritan, NJ | 0000 | 00.00 | 000000&0 | 00.00 |
000-000 0000000000 | Corporation | Hercules, CA | 0000 | 00.000 | 000000000 | 00.000 |
0000é00000 | Corporation | Marcy l'Etoile, France | 00000 | 00000 | 000000000 | 00000 |
000000000 | Corporate Backed or Acquired | Goettingen, Germany | 00000 | 000000&0 |
Bruker Patents
Bruker Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
DE-102022123559-B3 | Method and device for monitoring and controlling the performance of an ion source | Active | 15-Sep-2022 | 00 | |
GB-202300045-D0 | Method for determining an element concentration of an eds/wds spectrum of an unknow sample and a corresponding device | Pending | 21-Mar-2022 | 000000000 | |
GB-2616939-A | Method for determining an element concentration of an eds/wds spectrum of an unknown sample and a corresponding device | Pending | 21-Mar-2022 | 000000000 | |
EP-4249902-A1 | Method for determining an element concentration of an eds/wds spectrum of an unknown sample and a corresponding device | Pending | 21-Mar-2022 | 000000000 | 0 |
US-20230358695-A1 | Method for determining an element concentration of an eds/wds spectrum of an unknown sample and a corresponding device | Pending | 21-Mar-2022 | G01N23/2209 |
Bruker Executive Team (28)
Bruker Board Members (11)
Name | Representing | Role | Since |
---|---|---|---|
Adelene Perkins | Self | Board Member | 000 0000 |
Bonnie Anderson | Self | Board Member | 000 0000 |
Cynthia Friend Ph.D | Bruker | Board Member | 000 0000 |
Frank Laukien Ph.D | Bruker | Chief Executive Officer, President & Chairman | 000 0000 |
Hermann Requardt Ph.D | Bruker | Board Member | 000 0000 |
Bruker Signals
Bruker Investments & Acquisitions (84)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
MIRO (Electronic Equipment and Instruments) | 03-Oct-2023 | 0000000000 | Electronic Equipment and Instruments | ||
PhenomeX | 03-Oct-2023 | 0000000000 | 00000 | Drug Discovery | 0000 0000 |
Interherence | 03-Jul-2023 | 0000000000 | 000.00 | Monitoring Equipment | |
Kiyatec | 18-May-2023 | 00000 0000 | 0000 | Decision/Risk Analysis | |
Zontal | 04-May-2023 | Merger/Acquisition | IT Consulting and Outsourcing | 00000 000 |
Bruker Subsidiaries (24)
Company Name | Industry | Location | Founded |
---|---|---|---|
Interherence | Monitoring Equipment | Erlangen, Germany | 2019 |
MIRO (Electronic Equipment and Instruments) | Electronic Equipment and Instruments | Zurich, Switzerland | 0000 |
Canopy Biosciences | Discovery Tools (Healthcare) | Saint Louis, MO | 0000 |
Zontal | IT Consulting and Outsourcing | Plantation, FL | 0000 |
Molecubes | Other Healthcare Technology Systems | Gent, Belgium | 0000 |
Bruker ESG
Risk Overview
Risk Rating
Updated September, 14, 2022
20.71 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,708
Rank
Percentile

Pharmaceuticals
Industry
00 of 884
Rank
Percentile

Laboratory Equipment and Services
Subindustry
00 of 67
Rank
Percentile

Bruker Exits (5)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Haystack Oncology | 16-Nov-2022 | 00000 00000 00 | 0000 | Completed |
|
Bruker (ICP-MS Business) | 19-May-2010 | 000000000000000000 | Completed |
|
|
Spectral Solutions | 01-Jun-2007 | 000000000000000000 | Completed |
|
|
VACUUMSCHMELZE | 01-Jun-2003 | 000000000000000000 | Completed |
|
|
GeneFormatics | 01-Oct-2001 | Early Stage VC | 0000 | Completed |
|